Hyderabad Telangana, India

Chakilam Nagaraju



Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Secunderabad, IN (2006)
  • Hyderabad, IN (2013 - 2015)
  • Telangana, IN (2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chakilam Nagaraju

Introduction

Chakilam Nagaraju is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on innovative processes that enhance the preparation of various chemical compounds.

Latest Patents

One of Chakilam Nagaraju's latest patents is titled "Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4-fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereof." This invention relates to an improved method for synthesizing a specific compound, which is crucial for pharmaceutical applications. Another notable patent is "Process for the preparation of benzimidazole derivatives and its salts," which includes a dabigatran etexilate intermediate and its use in the preparation of dabigatran etexilate.

Career Highlights

Chakilam Nagaraju has worked with esteemed organizations such as MSN Laboratories Private Limited and Dr. Reddy's Laboratories, Incorporated. His experience in these companies has allowed him to develop and refine his innovative processes, contributing to advancements in the pharmaceutical industry.

Collaborations

Chakilam has collaborated with notable colleagues, including Manne Satyanarayana Reddy and Achampeta Kodanda Ramprasad. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Chakilam Nagaraju's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the industry positively, showcasing the importance of innovation in developing new pharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…